Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0SEEBD
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CD123-CPI ADC (Pfizer)
|
|||||
| Synonyms |
CD123-CPI-ADC; CD123 CPI ADC
Click to Show/Hide
|
|||||
| Organization |
Pfizer Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Acute myeloid leukaemia [ICD11:2A60]
Clinical candidate
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Interleukin-3 receptor subunit alpha (IL3RA)
|
Antigen Info | ||||
| Payload Name |
Cyclopropylpyrroloindoline (CPI) payload
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Combination Type |
Site-specific conjugation using the transglutaminase methodology
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.